Global Transfusion Diagnosis for Donor Supply, Demand and Key Producers, 2026-2032
The global Transfusion Diagnosis for Donor market size is expected to reach $ 6686 million by 2032, rising at a market growth of 5.4% CAGR during the forecast period (2026-2032).
The gross profit margin of major companies in the industry is between 50% ? 70%.
Transfusion Diagnosis for Donors refers to the critical medical screening and testing process performed on blood donors to ensure the safety and compatibility of blood products. This includes mandatory screening for transfusion-transmitted infections (TTIs) such as HIV, Hepatitis B and C, and Syphilis using Nucleic Acid Testing (NAT) and ELISA. It also encompasses blood group serology (ABO/Rh typing) and cross-matching. These procedures are fundamental to modern hemovigilance, ensuring every blood unit meets stringent clinical safety standards to prevent adverse reactions in recipients.
The industrial chain begins upstream with providers of biological raw materials (antigens, antibodies, enzymes), precision optical sensors, microfluidic chips, and high-purity reagents. The midstream consists of manufacturers of automated blood screening platforms, molecular diagnostic systems, and immunoassays. Downstream applications include national and regional blood centers, hospital blood banks, and plasma collection stations. The chain is supported by cold-chain logistics providers and regulatory bodies. Service providers offer calibration, system maintenance, and integrated blood management software to track blood units from collection to clinical transfusion, ensuring full traceability and safety.
The market for transfusion diagnosis is witnessing a significant shift toward automated and molecular-based testing to minimize the 'window period' of infection detection. Increasing global healthcare expenditures and aging populations are driving the demand for safe blood supplies. A key trend is the integration of Nucleic Acid Testing (NAT) with traditional serology to enhance sensitivity. Furthermore, the adoption of Big Data and AI in blood management systems is optimizing inventory and reducing wastage. While stringent regulatory requirements pose a high entry barrier, the expansion of blood banking infrastructure in emerging economies provides substantial growth opportunities. Manufacturers are focusing on high-throughput systems that reduce manual errors while maintaining the highest levels of diagnostic accuracy and safety.
This report studies the global Transfusion Diagnosis for Donor demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Transfusion Diagnosis for Donor, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transfusion Diagnosis for Donor that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Transfusion Diagnosis for Donor total market, 2021-2032, (USD Million)
Global Transfusion Diagnosis for Donor total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Transfusion Diagnosis for Donor total market, key domestic companies, and share, (USD Million)
Global Transfusion Diagnosis for Donor revenue by player, revenue and market share 2021-2026, (USD Million)
Global Transfusion Diagnosis for Donor total market by Type, CAGR, 2021-2032, (USD Million)
Global Transfusion Diagnosis for Donor total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Transfusion Diagnosis for Donor market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, F. Hoffmann-La Roche, Abbott, Bio-Rad Laboratories, Werfen, QuidelOrtho Corporation, AliveDx Holdings Finance, BAG Diagnostics GmbH, Diasorin, Prestige Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Transfusion Diagnosis for Donor market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Transfusion Diagnosis for Donor Market, By Region:
1. How big is the global Transfusion Diagnosis for Donor market?
2. What is the demand of the global Transfusion Diagnosis for Donor market?
3. What is the year over year growth of the global Transfusion Diagnosis for Donor market?
4. What is the total value of the global Transfusion Diagnosis for Donor market?
5. Who are the Major Players in the global Transfusion Diagnosis for Donor market?
6. What are the growth factors driving the market demand?
The gross profit margin of major companies in the industry is between 50% ? 70%.
Transfusion Diagnosis for Donors refers to the critical medical screening and testing process performed on blood donors to ensure the safety and compatibility of blood products. This includes mandatory screening for transfusion-transmitted infections (TTIs) such as HIV, Hepatitis B and C, and Syphilis using Nucleic Acid Testing (NAT) and ELISA. It also encompasses blood group serology (ABO/Rh typing) and cross-matching. These procedures are fundamental to modern hemovigilance, ensuring every blood unit meets stringent clinical safety standards to prevent adverse reactions in recipients.
The industrial chain begins upstream with providers of biological raw materials (antigens, antibodies, enzymes), precision optical sensors, microfluidic chips, and high-purity reagents. The midstream consists of manufacturers of automated blood screening platforms, molecular diagnostic systems, and immunoassays. Downstream applications include national and regional blood centers, hospital blood banks, and plasma collection stations. The chain is supported by cold-chain logistics providers and regulatory bodies. Service providers offer calibration, system maintenance, and integrated blood management software to track blood units from collection to clinical transfusion, ensuring full traceability and safety.
The market for transfusion diagnosis is witnessing a significant shift toward automated and molecular-based testing to minimize the 'window period' of infection detection. Increasing global healthcare expenditures and aging populations are driving the demand for safe blood supplies. A key trend is the integration of Nucleic Acid Testing (NAT) with traditional serology to enhance sensitivity. Furthermore, the adoption of Big Data and AI in blood management systems is optimizing inventory and reducing wastage. While stringent regulatory requirements pose a high entry barrier, the expansion of blood banking infrastructure in emerging economies provides substantial growth opportunities. Manufacturers are focusing on high-throughput systems that reduce manual errors while maintaining the highest levels of diagnostic accuracy and safety.
This report studies the global Transfusion Diagnosis for Donor demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Transfusion Diagnosis for Donor, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transfusion Diagnosis for Donor that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Transfusion Diagnosis for Donor total market, 2021-2032, (USD Million)
Global Transfusion Diagnosis for Donor total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Transfusion Diagnosis for Donor total market, key domestic companies, and share, (USD Million)
Global Transfusion Diagnosis for Donor revenue by player, revenue and market share 2021-2026, (USD Million)
Global Transfusion Diagnosis for Donor total market by Type, CAGR, 2021-2032, (USD Million)
Global Transfusion Diagnosis for Donor total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Transfusion Diagnosis for Donor market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, F. Hoffmann-La Roche, Abbott, Bio-Rad Laboratories, Werfen, QuidelOrtho Corporation, AliveDx Holdings Finance, BAG Diagnostics GmbH, Diasorin, Prestige Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Transfusion Diagnosis for Donor market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Transfusion Diagnosis for Donor Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Instruments
- Kits and Reagents
- Blood Grouping & Typing Diagnostics
- Infectious Disease Screening Diagnostics
- Immunoassay-Based Diagnostics
- Molecular Diagnostics
- Blood Banks
- Blood Donation/Transfusion Centers
- Others
- Grifols
- F. Hoffmann-La Roche
- Abbott
- Bio-Rad Laboratories
- Werfen
- QuidelOrtho Corporation
- AliveDx Holdings Finance
- BAG Diagnostics GmbH
- Diasorin
- Prestige Diagnostics
- Atlas Medical GmbH
- Lorne Laboratories
1. How big is the global Transfusion Diagnosis for Donor market?
2. What is the demand of the global Transfusion Diagnosis for Donor market?
3. What is the year over year growth of the global Transfusion Diagnosis for Donor market?
4. What is the total value of the global Transfusion Diagnosis for Donor market?
5. Who are the Major Players in the global Transfusion Diagnosis for Donor market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Transfusion Diagnosis for Donor Introduction
1.2 World Transfusion Diagnosis for Donor Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Transfusion Diagnosis for Donor Total Market by Region (by Headquarter Location)
1.3.1 World Transfusion Diagnosis for Donor Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Transfusion Diagnosis for Donor Revenue (2021-2032)
1.3.3 China Based Company Transfusion Diagnosis for Donor Revenue (2021-2032)
1.3.4 Europe Based Company Transfusion Diagnosis for Donor Revenue (2021-2032)
1.3.5 Japan Based Company Transfusion Diagnosis for Donor Revenue (2021-2032)
1.3.6 South Korea Based Company Transfusion Diagnosis for Donor Revenue (2021-2032)
1.3.7 ASEAN Based Company Transfusion Diagnosis for Donor Revenue (2021-2032)
1.3.8 India Based Company Transfusion Diagnosis for Donor Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Transfusion Diagnosis for Donor Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Transfusion Diagnosis for Donor Consumption Value (2021-2032)
2.2 World Transfusion Diagnosis for Donor Consumption Value by Region
2.2.1 World Transfusion Diagnosis for Donor Consumption Value by Region (2021-2026)
2.2.2 World Transfusion Diagnosis for Donor Consumption Value Forecast by Region (2027-2032)
2.3 United States Transfusion Diagnosis for Donor Consumption Value (2021-2032)
2.4 China Transfusion Diagnosis for Donor Consumption Value (2021-2032)
2.5 Europe Transfusion Diagnosis for Donor Consumption Value (2021-2032)
2.6 Japan Transfusion Diagnosis for Donor Consumption Value (2021-2032)
2.7 South Korea Transfusion Diagnosis for Donor Consumption Value (2021-2032)
2.8 ASEAN Transfusion Diagnosis for Donor Consumption Value (2021-2032)
2.9 India Transfusion Diagnosis for Donor Consumption Value (2021-2032)
3 WORLD TRANSFUSION DIAGNOSIS FOR DONOR COMPANIES COMPETITIVE ANALYSIS
3.1 World Transfusion Diagnosis for Donor Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Transfusion Diagnosis for Donor Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Transfusion Diagnosis for Donor in 2025
3.2.3 Global Concentration Ratios (CR8) for Transfusion Diagnosis for Donor in 2025
3.3 Transfusion Diagnosis for Donor Company Evaluation Quadrant
3.4 Transfusion Diagnosis for Donor Market: Overall Company Footprint Analysis
3.4.1 Transfusion Diagnosis for Donor Market: Region Footprint
3.4.2 Transfusion Diagnosis for Donor Market: Company Product Type Footprint
3.4.3 Transfusion Diagnosis for Donor Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Transfusion Diagnosis for Donor Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Transfusion Diagnosis for Donor Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Transfusion Diagnosis for Donor Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Transfusion Diagnosis for Donor Consumption Value Comparison
4.2.1 United States VS China: Transfusion Diagnosis for Donor Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Transfusion Diagnosis for Donor Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Transfusion Diagnosis for Donor Companies and Market Share, 2021-2026
4.3.1 United States Based Transfusion Diagnosis for Donor Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Transfusion Diagnosis for Donor Revenue, (2021-2026)
4.4 China Based Companies Transfusion Diagnosis for Donor Revenue and Market Share, 2021-2026
4.4.1 China Based Transfusion Diagnosis for Donor Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Transfusion Diagnosis for Donor Revenue, (2021-2026)
4.5 Rest of World Based Transfusion Diagnosis for Donor Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Transfusion Diagnosis for Donor Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Transfusion Diagnosis for Donor Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Transfusion Diagnosis for Donor Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Instruments
5.2.2 Kits and Reagents
5.3 Market Segment by Type
5.3.1 World Transfusion Diagnosis for Donor Market Size by Type (2021-2026)
5.3.2 World Transfusion Diagnosis for Donor Market Size by Type (2027-2032)
5.3.3 World Transfusion Diagnosis for Donor Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DIAGNOSTIC PURPOSE
6.1 World Transfusion Diagnosis for Donor Market Size Overview by Diagnostic Purpose: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Diagnostic Purpose
6.2.1 Blood Grouping & Typing Diagnostics
6.2.2 Infectious Disease Screening Diagnostics
6.3 Market Segment by Diagnostic Purpose
6.3.1 World Transfusion Diagnosis for Donor Market Size by Diagnostic Purpose (2021-2026)
6.3.2 World Transfusion Diagnosis for Donor Market Size by Diagnostic Purpose (2027-2032)
6.3.3 World Transfusion Diagnosis for Donor Market Size Market Share by Diagnostic Purpose (2027-2032)
7 MARKET ANALYSIS BY TESTING METHOD
7.1 World Transfusion Diagnosis for Donor Market Size Overview by Testing Method: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Testing Method
7.2.1 Immunoassay-Based Diagnostics
7.2.2 Molecular Diagnostics
7.3 Market Segment by Testing Method
7.3.1 World Transfusion Diagnosis for Donor Market Size by Testing Method (2021-2026)
7.3.2 World Transfusion Diagnosis for Donor Market Size by Testing Method (2027-2032)
7.3.3 World Transfusion Diagnosis for Donor Market Size Market Share by Testing Method (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Transfusion Diagnosis for Donor Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Blood Banks
8.2.2 Blood Donation/Transfusion Centers
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Transfusion Diagnosis for Donor Market Size by Application (2021-2026)
8.3.2 World Transfusion Diagnosis for Donor Market Size by Application (2027-2032)
8.3.3 World Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Grifols
9.1.1 Grifols Details
9.1.2 Grifols Major Business
9.1.3 Grifols Transfusion Diagnosis for Donor Product and Services
9.1.4 Grifols Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Grifols Recent Developments/Updates
9.1.6 Grifols Competitive Strengths & Weaknesses
9.2 F. Hoffmann-La Roche
9.2.1 F. Hoffmann-La Roche Details
9.2.2 F. Hoffmann-La Roche Major Business
9.2.3 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product and Services
9.2.4 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 F. Hoffmann-La Roche Recent Developments/Updates
9.2.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
9.3 Abbott
9.3.1 Abbott Details
9.3.2 Abbott Major Business
9.3.3 Abbott Transfusion Diagnosis for Donor Product and Services
9.3.4 Abbott Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Abbott Recent Developments/Updates
9.3.6 Abbott Competitive Strengths & Weaknesses
9.4 Bio-Rad Laboratories
9.4.1 Bio-Rad Laboratories Details
9.4.2 Bio-Rad Laboratories Major Business
9.4.3 Bio-Rad Laboratories Transfusion Diagnosis for Donor Product and Services
9.4.4 Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Bio-Rad Laboratories Recent Developments/Updates
9.4.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
9.5 Werfen
9.5.1 Werfen Details
9.5.2 Werfen Major Business
9.5.3 Werfen Transfusion Diagnosis for Donor Product and Services
9.5.4 Werfen Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Werfen Recent Developments/Updates
9.5.6 Werfen Competitive Strengths & Weaknesses
9.6 QuidelOrtho Corporation
9.6.1 QuidelOrtho Corporation Details
9.6.2 QuidelOrtho Corporation Major Business
9.6.3 QuidelOrtho Corporation Transfusion Diagnosis for Donor Product and Services
9.6.4 QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 QuidelOrtho Corporation Recent Developments/Updates
9.6.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
9.7 AliveDx Holdings Finance
9.7.1 AliveDx Holdings Finance Details
9.7.2 AliveDx Holdings Finance Major Business
9.7.3 AliveDx Holdings Finance Transfusion Diagnosis for Donor Product and Services
9.7.4 AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 AliveDx Holdings Finance Recent Developments/Updates
9.7.6 AliveDx Holdings Finance Competitive Strengths & Weaknesses
9.8 BAG Diagnostics GmbH
9.8.1 BAG Diagnostics GmbH Details
9.8.2 BAG Diagnostics GmbH Major Business
9.8.3 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product and Services
9.8.4 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 BAG Diagnostics GmbH Recent Developments/Updates
9.8.6 BAG Diagnostics GmbH Competitive Strengths & Weaknesses
9.9 Diasorin
9.9.1 Diasorin Details
9.9.2 Diasorin Major Business
9.9.3 Diasorin Transfusion Diagnosis for Donor Product and Services
9.9.4 Diasorin Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Diasorin Recent Developments/Updates
9.9.6 Diasorin Competitive Strengths & Weaknesses
9.10 Prestige Diagnostics
9.10.1 Prestige Diagnostics Details
9.10.2 Prestige Diagnostics Major Business
9.10.3 Prestige Diagnostics Transfusion Diagnosis for Donor Product and Services
9.10.4 Prestige Diagnostics Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Prestige Diagnostics Recent Developments/Updates
9.10.6 Prestige Diagnostics Competitive Strengths & Weaknesses
9.11 Atlas Medical GmbH
9.11.1 Atlas Medical GmbH Details
9.11.2 Atlas Medical GmbH Major Business
9.11.3 Atlas Medical GmbH Transfusion Diagnosis for Donor Product and Services
9.11.4 Atlas Medical GmbH Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Atlas Medical GmbH Recent Developments/Updates
9.11.6 Atlas Medical GmbH Competitive Strengths & Weaknesses
9.12 Lorne Laboratories
9.12.1 Lorne Laboratories Details
9.12.2 Lorne Laboratories Major Business
9.12.3 Lorne Laboratories Transfusion Diagnosis for Donor Product and Services
9.12.4 Lorne Laboratories Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Lorne Laboratories Recent Developments/Updates
9.12.6 Lorne Laboratories Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Transfusion Diagnosis for Donor Industry Chain
10.2 Transfusion Diagnosis for Donor Upstream Analysis
10.3 Transfusion Diagnosis for Donor Midstream Analysis
10.4 Transfusion Diagnosis for Donor Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Transfusion Diagnosis for Donor Introduction
1.2 World Transfusion Diagnosis for Donor Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Transfusion Diagnosis for Donor Total Market by Region (by Headquarter Location)
1.3.1 World Transfusion Diagnosis for Donor Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Transfusion Diagnosis for Donor Revenue (2021-2032)
1.3.3 China Based Company Transfusion Diagnosis for Donor Revenue (2021-2032)
1.3.4 Europe Based Company Transfusion Diagnosis for Donor Revenue (2021-2032)
1.3.5 Japan Based Company Transfusion Diagnosis for Donor Revenue (2021-2032)
1.3.6 South Korea Based Company Transfusion Diagnosis for Donor Revenue (2021-2032)
1.3.7 ASEAN Based Company Transfusion Diagnosis for Donor Revenue (2021-2032)
1.3.8 India Based Company Transfusion Diagnosis for Donor Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Transfusion Diagnosis for Donor Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Transfusion Diagnosis for Donor Consumption Value (2021-2032)
2.2 World Transfusion Diagnosis for Donor Consumption Value by Region
2.2.1 World Transfusion Diagnosis for Donor Consumption Value by Region (2021-2026)
2.2.2 World Transfusion Diagnosis for Donor Consumption Value Forecast by Region (2027-2032)
2.3 United States Transfusion Diagnosis for Donor Consumption Value (2021-2032)
2.4 China Transfusion Diagnosis for Donor Consumption Value (2021-2032)
2.5 Europe Transfusion Diagnosis for Donor Consumption Value (2021-2032)
2.6 Japan Transfusion Diagnosis for Donor Consumption Value (2021-2032)
2.7 South Korea Transfusion Diagnosis for Donor Consumption Value (2021-2032)
2.8 ASEAN Transfusion Diagnosis for Donor Consumption Value (2021-2032)
2.9 India Transfusion Diagnosis for Donor Consumption Value (2021-2032)
3 WORLD TRANSFUSION DIAGNOSIS FOR DONOR COMPANIES COMPETITIVE ANALYSIS
3.1 World Transfusion Diagnosis for Donor Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Transfusion Diagnosis for Donor Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Transfusion Diagnosis for Donor in 2025
3.2.3 Global Concentration Ratios (CR8) for Transfusion Diagnosis for Donor in 2025
3.3 Transfusion Diagnosis for Donor Company Evaluation Quadrant
3.4 Transfusion Diagnosis for Donor Market: Overall Company Footprint Analysis
3.4.1 Transfusion Diagnosis for Donor Market: Region Footprint
3.4.2 Transfusion Diagnosis for Donor Market: Company Product Type Footprint
3.4.3 Transfusion Diagnosis for Donor Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Transfusion Diagnosis for Donor Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Transfusion Diagnosis for Donor Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Transfusion Diagnosis for Donor Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Transfusion Diagnosis for Donor Consumption Value Comparison
4.2.1 United States VS China: Transfusion Diagnosis for Donor Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Transfusion Diagnosis for Donor Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Transfusion Diagnosis for Donor Companies and Market Share, 2021-2026
4.3.1 United States Based Transfusion Diagnosis for Donor Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Transfusion Diagnosis for Donor Revenue, (2021-2026)
4.4 China Based Companies Transfusion Diagnosis for Donor Revenue and Market Share, 2021-2026
4.4.1 China Based Transfusion Diagnosis for Donor Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Transfusion Diagnosis for Donor Revenue, (2021-2026)
4.5 Rest of World Based Transfusion Diagnosis for Donor Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Transfusion Diagnosis for Donor Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Transfusion Diagnosis for Donor Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Transfusion Diagnosis for Donor Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Instruments
5.2.2 Kits and Reagents
5.3 Market Segment by Type
5.3.1 World Transfusion Diagnosis for Donor Market Size by Type (2021-2026)
5.3.2 World Transfusion Diagnosis for Donor Market Size by Type (2027-2032)
5.3.3 World Transfusion Diagnosis for Donor Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DIAGNOSTIC PURPOSE
6.1 World Transfusion Diagnosis for Donor Market Size Overview by Diagnostic Purpose: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Diagnostic Purpose
6.2.1 Blood Grouping & Typing Diagnostics
6.2.2 Infectious Disease Screening Diagnostics
6.3 Market Segment by Diagnostic Purpose
6.3.1 World Transfusion Diagnosis for Donor Market Size by Diagnostic Purpose (2021-2026)
6.3.2 World Transfusion Diagnosis for Donor Market Size by Diagnostic Purpose (2027-2032)
6.3.3 World Transfusion Diagnosis for Donor Market Size Market Share by Diagnostic Purpose (2027-2032)
7 MARKET ANALYSIS BY TESTING METHOD
7.1 World Transfusion Diagnosis for Donor Market Size Overview by Testing Method: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Testing Method
7.2.1 Immunoassay-Based Diagnostics
7.2.2 Molecular Diagnostics
7.3 Market Segment by Testing Method
7.3.1 World Transfusion Diagnosis for Donor Market Size by Testing Method (2021-2026)
7.3.2 World Transfusion Diagnosis for Donor Market Size by Testing Method (2027-2032)
7.3.3 World Transfusion Diagnosis for Donor Market Size Market Share by Testing Method (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Transfusion Diagnosis for Donor Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Blood Banks
8.2.2 Blood Donation/Transfusion Centers
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Transfusion Diagnosis for Donor Market Size by Application (2021-2026)
8.3.2 World Transfusion Diagnosis for Donor Market Size by Application (2027-2032)
8.3.3 World Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Grifols
9.1.1 Grifols Details
9.1.2 Grifols Major Business
9.1.3 Grifols Transfusion Diagnosis for Donor Product and Services
9.1.4 Grifols Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Grifols Recent Developments/Updates
9.1.6 Grifols Competitive Strengths & Weaknesses
9.2 F. Hoffmann-La Roche
9.2.1 F. Hoffmann-La Roche Details
9.2.2 F. Hoffmann-La Roche Major Business
9.2.3 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product and Services
9.2.4 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 F. Hoffmann-La Roche Recent Developments/Updates
9.2.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
9.3 Abbott
9.3.1 Abbott Details
9.3.2 Abbott Major Business
9.3.3 Abbott Transfusion Diagnosis for Donor Product and Services
9.3.4 Abbott Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Abbott Recent Developments/Updates
9.3.6 Abbott Competitive Strengths & Weaknesses
9.4 Bio-Rad Laboratories
9.4.1 Bio-Rad Laboratories Details
9.4.2 Bio-Rad Laboratories Major Business
9.4.3 Bio-Rad Laboratories Transfusion Diagnosis for Donor Product and Services
9.4.4 Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Bio-Rad Laboratories Recent Developments/Updates
9.4.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
9.5 Werfen
9.5.1 Werfen Details
9.5.2 Werfen Major Business
9.5.3 Werfen Transfusion Diagnosis for Donor Product and Services
9.5.4 Werfen Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Werfen Recent Developments/Updates
9.5.6 Werfen Competitive Strengths & Weaknesses
9.6 QuidelOrtho Corporation
9.6.1 QuidelOrtho Corporation Details
9.6.2 QuidelOrtho Corporation Major Business
9.6.3 QuidelOrtho Corporation Transfusion Diagnosis for Donor Product and Services
9.6.4 QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 QuidelOrtho Corporation Recent Developments/Updates
9.6.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
9.7 AliveDx Holdings Finance
9.7.1 AliveDx Holdings Finance Details
9.7.2 AliveDx Holdings Finance Major Business
9.7.3 AliveDx Holdings Finance Transfusion Diagnosis for Donor Product and Services
9.7.4 AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 AliveDx Holdings Finance Recent Developments/Updates
9.7.6 AliveDx Holdings Finance Competitive Strengths & Weaknesses
9.8 BAG Diagnostics GmbH
9.8.1 BAG Diagnostics GmbH Details
9.8.2 BAG Diagnostics GmbH Major Business
9.8.3 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product and Services
9.8.4 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 BAG Diagnostics GmbH Recent Developments/Updates
9.8.6 BAG Diagnostics GmbH Competitive Strengths & Weaknesses
9.9 Diasorin
9.9.1 Diasorin Details
9.9.2 Diasorin Major Business
9.9.3 Diasorin Transfusion Diagnosis for Donor Product and Services
9.9.4 Diasorin Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Diasorin Recent Developments/Updates
9.9.6 Diasorin Competitive Strengths & Weaknesses
9.10 Prestige Diagnostics
9.10.1 Prestige Diagnostics Details
9.10.2 Prestige Diagnostics Major Business
9.10.3 Prestige Diagnostics Transfusion Diagnosis for Donor Product and Services
9.10.4 Prestige Diagnostics Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Prestige Diagnostics Recent Developments/Updates
9.10.6 Prestige Diagnostics Competitive Strengths & Weaknesses
9.11 Atlas Medical GmbH
9.11.1 Atlas Medical GmbH Details
9.11.2 Atlas Medical GmbH Major Business
9.11.3 Atlas Medical GmbH Transfusion Diagnosis for Donor Product and Services
9.11.4 Atlas Medical GmbH Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Atlas Medical GmbH Recent Developments/Updates
9.11.6 Atlas Medical GmbH Competitive Strengths & Weaknesses
9.12 Lorne Laboratories
9.12.1 Lorne Laboratories Details
9.12.2 Lorne Laboratories Major Business
9.12.3 Lorne Laboratories Transfusion Diagnosis for Donor Product and Services
9.12.4 Lorne Laboratories Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Lorne Laboratories Recent Developments/Updates
9.12.6 Lorne Laboratories Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Transfusion Diagnosis for Donor Industry Chain
10.2 Transfusion Diagnosis for Donor Upstream Analysis
10.3 Transfusion Diagnosis for Donor Midstream Analysis
10.4 Transfusion Diagnosis for Donor Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Transfusion Diagnosis for Donor Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Transfusion Diagnosis for Donor Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Transfusion Diagnosis for Donor Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Transfusion Diagnosis for Donor Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Transfusion Diagnosis for Donor Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Transfusion Diagnosis for Donor Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Transfusion Diagnosis for Donor Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Transfusion Diagnosis for Donor Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Transfusion Diagnosis for Donor Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Transfusion Diagnosis for Donor Players in 2025
Table 12. World Transfusion Diagnosis for Donor Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Transfusion Diagnosis for Donor Company Evaluation Quadrant
Table 14. Head Office of Key Transfusion Diagnosis for Donor Players
Table 15. Transfusion Diagnosis for Donor Market: Company Product Type Footprint
Table 16. Transfusion Diagnosis for Donor Market: Company Product Application Footprint
Table 17. Transfusion Diagnosis for Donor Mergers & Acquisitions Activity
Table 18. United States VS China Transfusion Diagnosis for Donor Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Transfusion Diagnosis for Donor Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Transfusion Diagnosis for Donor Companies, Headquarters (States, Country)
Table 21. United States Based Companies Transfusion Diagnosis for Donor Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Transfusion Diagnosis for Donor Revenue Market Share (2021-2026)
Table 23. China Based Transfusion Diagnosis for Donor Companies, Headquarters (Province, Country)
Table 24. China Based Companies Transfusion Diagnosis for Donor Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Transfusion Diagnosis for Donor Revenue Market Share (2021-2026)
Table 26. Rest of World Based Transfusion Diagnosis for Donor Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Transfusion Diagnosis for Donor Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Transfusion Diagnosis for Donor Revenue Market Share (2021-2026)
Table 29. World Transfusion Diagnosis for Donor Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Transfusion Diagnosis for Donor Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Transfusion Diagnosis for Donor Market Size by Type (2027-2032) & (USD Million)
Table 32. World Transfusion Diagnosis for Donor Market Size by Diagnostic Purpose, (USD Million), 2021 & 2025 & 2032
Table 33. World Transfusion Diagnosis for Donor Market Size Value by Diagnostic Purpose (2021-2026) & (USD Million)
Table 34. World Transfusion Diagnosis for Donor Market Size by Diagnostic Purpose (2027-2032) & (USD Million)
Table 35. World Transfusion Diagnosis for Donor Market Size by Testing Method, (USD Million), 2021 & 2025 & 2032
Table 36. World Transfusion Diagnosis for Donor Market Size Value by Testing Method (2021-2026) & (USD Million)
Table 37. World Transfusion Diagnosis for Donor Market Size by Testing Method (2027-2032) & (USD Million)
Table 38. World Transfusion Diagnosis for Donor Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & (USD Million)
Table 40. World Transfusion Diagnosis for Donor Market Size by Application (2027-2032) & (USD Million)
Table 41. Grifols Basic Information, Manufacturing Base and Competitors
Table 42. Grifols Major Business
Table 43. Grifols Transfusion Diagnosis for Donor Product and Services
Table 44. Grifols Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Grifols Recent Developments/Updates
Table 46. Grifols Competitive Strengths & Weaknesses
Table 47. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 48. F. Hoffmann-La Roche Major Business
Table 49. F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product and Services
Table 50. F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. F. Hoffmann-La Roche Recent Developments/Updates
Table 52. F. Hoffmann-La Roche Competitive Strengths & Weaknesses
Table 53. Abbott Basic Information, Manufacturing Base and Competitors
Table 54. Abbott Major Business
Table 55. Abbott Transfusion Diagnosis for Donor Product and Services
Table 56. Abbott Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Abbott Recent Developments/Updates
Table 58. Abbott Competitive Strengths & Weaknesses
Table 59. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 60. Bio-Rad Laboratories Major Business
Table 61. Bio-Rad Laboratories Transfusion Diagnosis for Donor Product and Services
Table 62. Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Bio-Rad Laboratories Recent Developments/Updates
Table 64. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 65. Werfen Basic Information, Manufacturing Base and Competitors
Table 66. Werfen Major Business
Table 67. Werfen Transfusion Diagnosis for Donor Product and Services
Table 68. Werfen Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Werfen Recent Developments/Updates
Table 70. Werfen Competitive Strengths & Weaknesses
Table 71. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 72. QuidelOrtho Corporation Major Business
Table 73. QuidelOrtho Corporation Transfusion Diagnosis for Donor Product and Services
Table 74. QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. QuidelOrtho Corporation Recent Developments/Updates
Table 76. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 77. AliveDx Holdings Finance Basic Information, Manufacturing Base and Competitors
Table 78. AliveDx Holdings Finance Major Business
Table 79. AliveDx Holdings Finance Transfusion Diagnosis for Donor Product and Services
Table 80. AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. AliveDx Holdings Finance Recent Developments/Updates
Table 82. AliveDx Holdings Finance Competitive Strengths & Weaknesses
Table 83. BAG Diagnostics GmbH Basic Information, Manufacturing Base and Competitors
Table 84. BAG Diagnostics GmbH Major Business
Table 85. BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product and Services
Table 86. BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. BAG Diagnostics GmbH Recent Developments/Updates
Table 88. BAG Diagnostics GmbH Competitive Strengths & Weaknesses
Table 89. Diasorin Basic Information, Manufacturing Base and Competitors
Table 90. Diasorin Major Business
Table 91. Diasorin Transfusion Diagnosis for Donor Product and Services
Table 92. Diasorin Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Diasorin Recent Developments/Updates
Table 94. Diasorin Competitive Strengths & Weaknesses
Table 95. Prestige Diagnostics Basic Information, Manufacturing Base and Competitors
Table 96. Prestige Diagnostics Major Business
Table 97. Prestige Diagnostics Transfusion Diagnosis for Donor Product and Services
Table 98. Prestige Diagnostics Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Prestige Diagnostics Recent Developments/Updates
Table 100. Prestige Diagnostics Competitive Strengths & Weaknesses
Table 101. Atlas Medical GmbH Basic Information, Manufacturing Base and Competitors
Table 102. Atlas Medical GmbH Major Business
Table 103. Atlas Medical GmbH Transfusion Diagnosis for Donor Product and Services
Table 104. Atlas Medical GmbH Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Atlas Medical GmbH Recent Developments/Updates
Table 106. Atlas Medical GmbH Competitive Strengths & Weaknesses
Table 107. Lorne Laboratories Basic Information, Manufacturing Base and Competitors
Table 108. Lorne Laboratories Major Business
Table 109. Lorne Laboratories Transfusion Diagnosis for Donor Product and Services
Table 110. Lorne Laboratories Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Lorne Laboratories Recent Developments/Updates
Table 112. Lorne Laboratories Competitive Strengths & Weaknesses
Table 113. Global Key Players of Transfusion Diagnosis for Donor Upstream (Raw Materials)
Table 114. Global Transfusion Diagnosis for Donor Typical Customers
Table 1. World Transfusion Diagnosis for Donor Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Transfusion Diagnosis for Donor Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Transfusion Diagnosis for Donor Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Transfusion Diagnosis for Donor Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Transfusion Diagnosis for Donor Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Transfusion Diagnosis for Donor Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Transfusion Diagnosis for Donor Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Transfusion Diagnosis for Donor Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Transfusion Diagnosis for Donor Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Transfusion Diagnosis for Donor Players in 2025
Table 12. World Transfusion Diagnosis for Donor Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Transfusion Diagnosis for Donor Company Evaluation Quadrant
Table 14. Head Office of Key Transfusion Diagnosis for Donor Players
Table 15. Transfusion Diagnosis for Donor Market: Company Product Type Footprint
Table 16. Transfusion Diagnosis for Donor Market: Company Product Application Footprint
Table 17. Transfusion Diagnosis for Donor Mergers & Acquisitions Activity
Table 18. United States VS China Transfusion Diagnosis for Donor Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Transfusion Diagnosis for Donor Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Transfusion Diagnosis for Donor Companies, Headquarters (States, Country)
Table 21. United States Based Companies Transfusion Diagnosis for Donor Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Transfusion Diagnosis for Donor Revenue Market Share (2021-2026)
Table 23. China Based Transfusion Diagnosis for Donor Companies, Headquarters (Province, Country)
Table 24. China Based Companies Transfusion Diagnosis for Donor Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Transfusion Diagnosis for Donor Revenue Market Share (2021-2026)
Table 26. Rest of World Based Transfusion Diagnosis for Donor Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Transfusion Diagnosis for Donor Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Transfusion Diagnosis for Donor Revenue Market Share (2021-2026)
Table 29. World Transfusion Diagnosis for Donor Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Transfusion Diagnosis for Donor Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Transfusion Diagnosis for Donor Market Size by Type (2027-2032) & (USD Million)
Table 32. World Transfusion Diagnosis for Donor Market Size by Diagnostic Purpose, (USD Million), 2021 & 2025 & 2032
Table 33. World Transfusion Diagnosis for Donor Market Size Value by Diagnostic Purpose (2021-2026) & (USD Million)
Table 34. World Transfusion Diagnosis for Donor Market Size by Diagnostic Purpose (2027-2032) & (USD Million)
Table 35. World Transfusion Diagnosis for Donor Market Size by Testing Method, (USD Million), 2021 & 2025 & 2032
Table 36. World Transfusion Diagnosis for Donor Market Size Value by Testing Method (2021-2026) & (USD Million)
Table 37. World Transfusion Diagnosis for Donor Market Size by Testing Method (2027-2032) & (USD Million)
Table 38. World Transfusion Diagnosis for Donor Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Transfusion Diagnosis for Donor Market Size by Application (2021-2026) & (USD Million)
Table 40. World Transfusion Diagnosis for Donor Market Size by Application (2027-2032) & (USD Million)
Table 41. Grifols Basic Information, Manufacturing Base and Competitors
Table 42. Grifols Major Business
Table 43. Grifols Transfusion Diagnosis for Donor Product and Services
Table 44. Grifols Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Grifols Recent Developments/Updates
Table 46. Grifols Competitive Strengths & Weaknesses
Table 47. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 48. F. Hoffmann-La Roche Major Business
Table 49. F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product and Services
Table 50. F. Hoffmann-La Roche Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. F. Hoffmann-La Roche Recent Developments/Updates
Table 52. F. Hoffmann-La Roche Competitive Strengths & Weaknesses
Table 53. Abbott Basic Information, Manufacturing Base and Competitors
Table 54. Abbott Major Business
Table 55. Abbott Transfusion Diagnosis for Donor Product and Services
Table 56. Abbott Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Abbott Recent Developments/Updates
Table 58. Abbott Competitive Strengths & Weaknesses
Table 59. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 60. Bio-Rad Laboratories Major Business
Table 61. Bio-Rad Laboratories Transfusion Diagnosis for Donor Product and Services
Table 62. Bio-Rad Laboratories Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Bio-Rad Laboratories Recent Developments/Updates
Table 64. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 65. Werfen Basic Information, Manufacturing Base and Competitors
Table 66. Werfen Major Business
Table 67. Werfen Transfusion Diagnosis for Donor Product and Services
Table 68. Werfen Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Werfen Recent Developments/Updates
Table 70. Werfen Competitive Strengths & Weaknesses
Table 71. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 72. QuidelOrtho Corporation Major Business
Table 73. QuidelOrtho Corporation Transfusion Diagnosis for Donor Product and Services
Table 74. QuidelOrtho Corporation Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. QuidelOrtho Corporation Recent Developments/Updates
Table 76. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 77. AliveDx Holdings Finance Basic Information, Manufacturing Base and Competitors
Table 78. AliveDx Holdings Finance Major Business
Table 79. AliveDx Holdings Finance Transfusion Diagnosis for Donor Product and Services
Table 80. AliveDx Holdings Finance Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. AliveDx Holdings Finance Recent Developments/Updates
Table 82. AliveDx Holdings Finance Competitive Strengths & Weaknesses
Table 83. BAG Diagnostics GmbH Basic Information, Manufacturing Base and Competitors
Table 84. BAG Diagnostics GmbH Major Business
Table 85. BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product and Services
Table 86. BAG Diagnostics GmbH Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. BAG Diagnostics GmbH Recent Developments/Updates
Table 88. BAG Diagnostics GmbH Competitive Strengths & Weaknesses
Table 89. Diasorin Basic Information, Manufacturing Base and Competitors
Table 90. Diasorin Major Business
Table 91. Diasorin Transfusion Diagnosis for Donor Product and Services
Table 92. Diasorin Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Diasorin Recent Developments/Updates
Table 94. Diasorin Competitive Strengths & Weaknesses
Table 95. Prestige Diagnostics Basic Information, Manufacturing Base and Competitors
Table 96. Prestige Diagnostics Major Business
Table 97. Prestige Diagnostics Transfusion Diagnosis for Donor Product and Services
Table 98. Prestige Diagnostics Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Prestige Diagnostics Recent Developments/Updates
Table 100. Prestige Diagnostics Competitive Strengths & Weaknesses
Table 101. Atlas Medical GmbH Basic Information, Manufacturing Base and Competitors
Table 102. Atlas Medical GmbH Major Business
Table 103. Atlas Medical GmbH Transfusion Diagnosis for Donor Product and Services
Table 104. Atlas Medical GmbH Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Atlas Medical GmbH Recent Developments/Updates
Table 106. Atlas Medical GmbH Competitive Strengths & Weaknesses
Table 107. Lorne Laboratories Basic Information, Manufacturing Base and Competitors
Table 108. Lorne Laboratories Major Business
Table 109. Lorne Laboratories Transfusion Diagnosis for Donor Product and Services
Table 110. Lorne Laboratories Transfusion Diagnosis for Donor Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Lorne Laboratories Recent Developments/Updates
Table 112. Lorne Laboratories Competitive Strengths & Weaknesses
Table 113. Global Key Players of Transfusion Diagnosis for Donor Upstream (Raw Materials)
Table 114. Global Transfusion Diagnosis for Donor Typical Customers
LIST OF FIGURES
Figure 1. Transfusion Diagnosis for Donor Picture
Figure 2. World Transfusion Diagnosis for Donor Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Transfusion Diagnosis for Donor Total Revenue (2021-2032) & (USD Million)
Figure 4. World Transfusion Diagnosis for Donor Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Transfusion Diagnosis for Donor Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Transfusion Diagnosis for Donor Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Transfusion Diagnosis for Donor Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Transfusion Diagnosis for Donor Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Transfusion Diagnosis for Donor Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Transfusion Diagnosis for Donor Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Transfusion Diagnosis for Donor Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Transfusion Diagnosis for Donor Revenue (2021-2032) & (USD Million)
Figure 13. Transfusion Diagnosis for Donor Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 16. World Transfusion Diagnosis for Donor Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 18. China Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 23. India Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Transfusion Diagnosis for Donor by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Transfusion Diagnosis for Donor Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Transfusion Diagnosis for Donor Markets in 2025
Figure 27. United States VS China: Transfusion Diagnosis for Donor Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Transfusion Diagnosis for Donor Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Transfusion Diagnosis for Donor Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Transfusion Diagnosis for Donor Market Size Market Share by Type in 2025
Figure 31. Instruments
Figure 32. Kits and Reagents
Figure 33. World Transfusion Diagnosis for Donor Market Size Market Share by Type (2021-2032)
Figure 34. World Transfusion Diagnosis for Donor Market Size by Diagnostic Purpose, (USD Million), 2021 & 2025 & 2032
Figure 35. World Transfusion Diagnosis for Donor Market Size Market Share by Diagnostic Purpose in 2025
Figure 36. Blood Grouping & Typing Diagnostics
Figure 37. Infectious Disease Screening Diagnostics
Figure 38. World Transfusion Diagnosis for Donor Market Size Market Share by Diagnostic Purpose (2021-2032)
Figure 39. World Transfusion Diagnosis for Donor Market Size by Testing Method, (USD Million), 2021 & 2025 & 2032
Figure 40. World Transfusion Diagnosis for Donor Market Size Market Share by Testing Method in 2025
Figure 41. Immunoassay-Based Diagnostics
Figure 42. Molecular Diagnostics
Figure 43. World Transfusion Diagnosis for Donor Market Size Market Share by Testing Method (2021-2032)
Figure 44. World Transfusion Diagnosis for Donor Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 45. World Transfusion Diagnosis for Donor Market Size Market Share by Application in 2025
Figure 46. Blood Banks
Figure 47. Blood Donation/Transfusion Centers
Figure 48. Others
Figure 49. World Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2032)
Figure 50. Transfusion Diagnosis for Donor Industrial Chain
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Transfusion Diagnosis for Donor Picture
Figure 2. World Transfusion Diagnosis for Donor Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Transfusion Diagnosis for Donor Total Revenue (2021-2032) & (USD Million)
Figure 4. World Transfusion Diagnosis for Donor Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Transfusion Diagnosis for Donor Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Transfusion Diagnosis for Donor Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Transfusion Diagnosis for Donor Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Transfusion Diagnosis for Donor Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Transfusion Diagnosis for Donor Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Transfusion Diagnosis for Donor Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Transfusion Diagnosis for Donor Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Transfusion Diagnosis for Donor Revenue (2021-2032) & (USD Million)
Figure 13. Transfusion Diagnosis for Donor Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 16. World Transfusion Diagnosis for Donor Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 18. China Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 23. India Transfusion Diagnosis for Donor Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Transfusion Diagnosis for Donor by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Transfusion Diagnosis for Donor Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Transfusion Diagnosis for Donor Markets in 2025
Figure 27. United States VS China: Transfusion Diagnosis for Donor Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Transfusion Diagnosis for Donor Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Transfusion Diagnosis for Donor Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Transfusion Diagnosis for Donor Market Size Market Share by Type in 2025
Figure 31. Instruments
Figure 32. Kits and Reagents
Figure 33. World Transfusion Diagnosis for Donor Market Size Market Share by Type (2021-2032)
Figure 34. World Transfusion Diagnosis for Donor Market Size by Diagnostic Purpose, (USD Million), 2021 & 2025 & 2032
Figure 35. World Transfusion Diagnosis for Donor Market Size Market Share by Diagnostic Purpose in 2025
Figure 36. Blood Grouping & Typing Diagnostics
Figure 37. Infectious Disease Screening Diagnostics
Figure 38. World Transfusion Diagnosis for Donor Market Size Market Share by Diagnostic Purpose (2021-2032)
Figure 39. World Transfusion Diagnosis for Donor Market Size by Testing Method, (USD Million), 2021 & 2025 & 2032
Figure 40. World Transfusion Diagnosis for Donor Market Size Market Share by Testing Method in 2025
Figure 41. Immunoassay-Based Diagnostics
Figure 42. Molecular Diagnostics
Figure 43. World Transfusion Diagnosis for Donor Market Size Market Share by Testing Method (2021-2032)
Figure 44. World Transfusion Diagnosis for Donor Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 45. World Transfusion Diagnosis for Donor Market Size Market Share by Application in 2025
Figure 46. Blood Banks
Figure 47. Blood Donation/Transfusion Centers
Figure 48. Others
Figure 49. World Transfusion Diagnosis for Donor Market Size Market Share by Application (2021-2032)
Figure 50. Transfusion Diagnosis for Donor Industrial Chain
Figure 51. Methodology
Figure 52. Research Process and Data Source
